Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES | 10,632,113 | 9,212,384 | -1,419,729 | 192,548 | 262,000 | 52.36% | +69,453 |
| ENGENE HOLDINGS INC COM | 9,632,561 | 9,632,561 | 0 | 35,063 | 65,790 | 13.15% | +30,728 |
| VOR BIOPHARMA INC(VOR) | 0 | 379,640 | +379,640 | 0 | 18,496 | 3.70% | +18,496 |
| DYNE THERAPEUTICS INC(DYN) | 5,462,846 | 5,462,846 | 0 | 52,006 | 69,105 | 13.81% | +17,099 |
| ASTRIA THERAPEUTICS INC | 4,107,537 | 4,107,537 | 0 | 23,413 | 29,903 | 5.98% | +6,490 |
| RAPT THERAPEUTICS INC | 440,176 | 344,237 | -95,939 | 3,451 | 8,878 | 1.77% | +5,427 |
| BICYCLE THERAPEUTICS PLC | 3,452,330 | 3,452,330 | 0 | 23,994 | 26,721 | 5.34% | +2,727 |
| ENGENE HOLDINGS INC *W EXP 10/31/202 | 2,878,148 | 2,878,148 | 0 | 2,360 | 2,072 | 0.41% | -288 |
| REPLIMUNE GROUP INC(REPL) | 3,909,696 | 4,158,368 | +248,672 | 36,321 | 17,424 | 3.48% | -18,898 |